· 个股论点

用私有CPO玩家估值论证SIVE作为上游激光瓶颈应获得更高估值。

涉及标的:

中文翻译

给试图做 $SIVE 估值分析的人: Ayar、Celestial、Lightmatter、Lightelligence 今天大概估值约40亿到150亿美元以上。 Sivers 市值约26亿美元,而且很可能是它们所有人的上游激光供应商。 我甚至还没把 Poet、TFLN 相关的 Hyperlight/Lightium,或 Jabil 和其他未披露可插拔玩家纳入估值分析。 也没包括 CHIPS Act 合同、Apple/Nokia 关系,或 Aeva 等人形/物理 AI 业务。 散户对私募市场不太熟悉……但这些公司都被视为前沿 CPO 玩家,并且估值和规模都在迅速增长。 所以我预计 $SIVE 应该获得类似甚至更高估值,因为它有激光瓶颈溢价。尤其是在它通过并购扩展 TAM 和收入之后。 下个月 BlackRock/Vanguard/MSCI/NASDAQ 新资金流入会随时间缩小差距。 但 NASDAQ 上市可能才是真正给 Sivers 溢价的因素。

英文原文

For people trying to do valuation analysis on $SIVE. Ayar, Celestial, Lightmatter, Lightelligence are probably valued probably ~$4B-15B+ today. Sivers is ~$2.6B MC and they're likely upstream laser for them all. I'm not even including Poet, TFLN links like Hyperlight/Lightium, or pluggables like Jabil + other undisclosed players in valuation analysis. Or their other segments like CHIPS Act contracts or Apple/Nokia relationships. Or humanoid/physical AI segments with Aeva + others. Retail aren't as familiar with private markets... But these companies are all considered the frontier CPO players, and are growing valuations/scaling rapidly. So, I'd expect $SIVE to command similar if not higher valuations given laser chokepoint premiums. Especially after they pull off M&A to TAM expand revenue. New Blackrock/Vanguard/MSCI/NASDAQ inflow next month helps close that gap over time. But NASDAQ listing is probably what gives Sivers a premium.

在 X 上查看原推 ↗